36 results
Thumbnail

D1.297 - Clinical characteristics of red meat allergy in 19 cases in Jeju

Thumbnail

D1.289 - The buzz that nearly broke a heart: A case of Kounis Syndrome following a Hymenoptera sting

Thumbnail

D1.290 - Identification of a Cheese-Derived κ-Casein Fragment as the Trigger of Anaphylaxis in a Patient with Suspected Pasta Allergy

Thumbnail

D1.291 - Real-world data of nasal adrenaline spray in anaphylaxis: Review of clinical evidence

Thumbnail

D1.292 - Anaphylaxis After Roasted Sunflower Seed Consumption in an Adult: A Case Report

Thumbnail

D1.293 - Hidden allergens revealed by prick-to-prick testing: anaphylaxis triggered by black pepper and cumin

Thumbnail

D1.295 - Patient Perceived Lifestyle Burden with a Nasal Adrenaline Spray vs an Adrenaline Auto- Injector

Thumbnail

D1.296 - Nasal Adrenaline Spray vs Adrenaline Auto-Injectors: When Will People Act?

Thumbnail

D1.298 - Does Previous Anaphylaxis Determine Differences between Patients Undergoing Oral Food Challenges to Cow’s Milk and Hen’s Egg?

Thumbnail

D1.299 - Lychee-Induced Anaphylaxis: Data from the French Allergy-Vigilance Network since 2002

Thumbnail

D1.301 - Non-specific lipid transfer protein allergy: the culprit in disguise

Thumbnail

D1.302 - Allergic Reactions Following Measles-Mumps-Rubella Vaccination in Children with Food Allergy: A Single Center Experience

Thumbnail

D1.437 - A Decade of Research on Janus Kinase Inhibitors in Atopic Dermatitis: A Global Bibliometric Analysis (2015–2024)

Thumbnail

D1.438 - Dupilumab for Moderate-to-Severe Atopic Dermatitis in Children and Adolescents: Real-Life Assessment of Efficacy and Safety

Thumbnail

D1.442 - Design and Preclinical Development of a Bispecific Antibody Targeting IL11 and TL1A

Thumbnail

D1.443 - Preclinical Development of a Dual LIGHT/TL1A Bispecific Antibody

Thumbnail

D1.446 - Lebrikizumab in patients with urticarial vasculitis - a case series

Thumbnail

D1.447 - Comparison of Disease Duration, Remission, and Other Disease-Related Parameters with the Duration of Omalizumab Treatment in Patients with Chronic Spontaneous Urticaria

Thumbnail

D1.448 - Long-Term Efficacy and Stability of Lebrikizumab in Treating Face/Head and Neck Involvement in Patients with Moderate-to-Severe Atopic Dermatitis

Thumbnail

D1.449 - A Phase 2, Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Briquilimab in Adults with Chronic Urticaria (Trial in Progress)